PET/MRI imaging in neuroendocrine neoplasm

Mayur K. Virarkar; Matthew Montanarella; Malak Itani; Luis Calimano-Ramirez; Dheeraj Gopireddy; Priya Bhosale

doi:10.1007/s00261-022-03757-1

PET/MRI imaging in neuroendocrine neoplasm

Mayur K. Virarkar, Matthew Montanarella, Malak Itani, Luis Calimano-Ramirez, Dheeraj Gopireddy, Priya Bhosale

Abdominal Imaging

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

Molecular imaging plays a vital role in the management of neuroendocrine neoplasms (NENs). Somatostatin receptor (SSTR) PET is critical for evaluating NENs, ascertaining peptide receptor radionuclide therapy (PRRT) eligibility, and treatment response. SSTR-PET/MRI can provide a one-stop-shop multiparametric evaluation of NENs. The acquisition of complementary imaging information in PET/MRI has distinct advantages over PET/CT and MR imaging acquisitions. The purpose of this manuscript is to provide a comprehensive overview of PET/MRI and a current review of recent PET/MRI advances in the diagnosis, staging, treatment, and surveillance of NENs.

Original language	English (US)
Pages (from-to)	3585-3600
Number of pages	16
Journal	Abdominal Radiology
Volume	48
Issue number	12
DOIs	https://doi.org/10.1007/s00261-022-03757-1
State	Published - Dec 2023

Keywords

Neuroendocrine neoplasm
PET/CT
PET/MRI
PPRT
SSTR

ASJC Scopus subject areas

Radiological and Ultrasound Technology
Radiology Nuclear Medicine and imaging
Gastroenterology
Urology

Access to Document

10.1007/s00261-022-03757-1

Cite this

@article{fa15f43c55314c9eab187d18ae716fef,

title = "PET/MRI imaging in neuroendocrine neoplasm",

abstract = "Molecular imaging plays a vital role in the management of neuroendocrine neoplasms (NENs). Somatostatin receptor (SSTR) PET is critical for evaluating NENs, ascertaining peptide receptor radionuclide therapy (PRRT) eligibility, and treatment response. SSTR-PET/MRI can provide a one-stop-shop multiparametric evaluation of NENs. The acquisition of complementary imaging information in PET/MRI has distinct advantages over PET/CT and MR imaging acquisitions. The purpose of this manuscript is to provide a comprehensive overview of PET/MRI and a current review of recent PET/MRI advances in the diagnosis, staging, treatment, and surveillance of NENs.",

keywords = "Neuroendocrine neoplasm, PET/CT, PET/MRI, PPRT, SSTR",

author = "Virarkar, {Mayur K.} and Matthew Montanarella and Malak Itani and Luis Calimano-Ramirez and Dheeraj Gopireddy and Priya Bhosale",

note = "Publisher Copyright: {\textcopyright} 2022, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.",

year = "2023",

month = dec,

doi = "10.1007/s00261-022-03757-1",

language = "English (US)",

volume = "48",

pages = "3585--3600",

journal = "Abdominal Radiology",

issn = "2366-004X",

publisher = "Springer New York",

number = "12",

}

TY - JOUR

T1 - PET/MRI imaging in neuroendocrine neoplasm

AU - Virarkar, Mayur K.

AU - Montanarella, Matthew

AU - Itani, Malak

AU - Calimano-Ramirez, Luis

AU - Gopireddy, Dheeraj

AU - Bhosale, Priya

PY - 2023/12

Y1 - 2023/12

N2 - Molecular imaging plays a vital role in the management of neuroendocrine neoplasms (NENs). Somatostatin receptor (SSTR) PET is critical for evaluating NENs, ascertaining peptide receptor radionuclide therapy (PRRT) eligibility, and treatment response. SSTR-PET/MRI can provide a one-stop-shop multiparametric evaluation of NENs. The acquisition of complementary imaging information in PET/MRI has distinct advantages over PET/CT and MR imaging acquisitions. The purpose of this manuscript is to provide a comprehensive overview of PET/MRI and a current review of recent PET/MRI advances in the diagnosis, staging, treatment, and surveillance of NENs.

AB - Molecular imaging plays a vital role in the management of neuroendocrine neoplasms (NENs). Somatostatin receptor (SSTR) PET is critical for evaluating NENs, ascertaining peptide receptor radionuclide therapy (PRRT) eligibility, and treatment response. SSTR-PET/MRI can provide a one-stop-shop multiparametric evaluation of NENs. The acquisition of complementary imaging information in PET/MRI has distinct advantages over PET/CT and MR imaging acquisitions. The purpose of this manuscript is to provide a comprehensive overview of PET/MRI and a current review of recent PET/MRI advances in the diagnosis, staging, treatment, and surveillance of NENs.

KW - Neuroendocrine neoplasm

KW - PET/CT

KW - PET/MRI

KW - PPRT

KW - SSTR

UR - http://www.scopus.com/inward/record.url?scp=85144114401&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85144114401&partnerID=8YFLogxK

U2 - 10.1007/s00261-022-03757-1

DO - 10.1007/s00261-022-03757-1

M3 - Article

C2 - 36525051

AN - SCOPUS:85144114401

SN - 2366-004X

VL - 48

SP - 3585

EP - 3600

JO - Abdominal Radiology

JF - Abdominal Radiology

IS - 12

ER -

PET/MRI imaging in neuroendocrine neoplasm

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this